Skip Navigation

JNCI Journal of the National Cancer Institute 2003 95(23):1742-1744; doi:10.1093/jnci/95.23.1742
© 2003 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Tenenbaum, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tenenbaum, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 Oxford University Press

NEWS

What’s All the Buzz? Fruit Flies Provide Unique Model for Cancer Research

David Tenenbaum

The first 150 words of the full text of this article appear below.

For almost a century, the fruit fly Drosophila melanogaster has been a workhorse of genetics and developmental biology: Genetically diverse, it is prolific, easy, and cheap to culture. Research with fruit flies dates to 1909, when Thomas Hunt Morgan of Columbia University started using them as a cheap, simple basis for experiments on genetics and development. This classic research subject has been used in several recent studies that have helped define the role of various genes in cancer.


Figure Removed (Available Only in the Full Text)
View larger version (78K):
[in this window]
[in a new window]
  		The fruit fly Drosophila melanogaster has been a workhorse of genetics and developmental biology for almost a century. This classic research subject has been used in several recent studies that have helped define the role of various genes in cancer. (©Lizzie Harper/Photo Researchers, Inc.)

 
Gerald Rubin, Ph.D., vice president for biomedical research at Howard Hughes Medical Institute and a veteran Drosophila researcher, said that cancer researchers have been using Drosophila "for a . . . [Full Text of this Article]

What Advantages?

What’s It Worth?


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
M. Dominguez
Interplay between Notch Signaling and Epigenetic Silencers in Cancer.
Cancer Res., September 15, 2006; 66(18): 8931 - 8934.
[Abstract] [Full Text] [PDF]